Nov-11 -

Melanoma Group

EORTC 18952 – Post-operative adjuvant Interferon-alpha 2b (Intron-A) treatment after resection of thick primary melanoma and/or regional lymphnode metastases “intermediate-high dose” vs “intermediate-low dose” Interferon-alpha vs observation.

Randomized phase III trial.

EORTC found that additional interferon treatment improves overall survival, in patients with stage III ulcerated melanoma.

READ MORE